Stigall L. Jeremy (CIK 0001929859)

Latest company ownership

Role: Chief Business Officer
Shares held
72,355
Last filed at
Jul 2, 2025
Confidence Score
49.6
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 10, 2025 Jun 12, 2025 ClearPoint Neuro, Inc. Chief Business Officer Sell 46.3 -3,561 -4.79% $47.3K
Mar 12, 2025 Mar 14, 2025 ClearPoint Neuro, Inc. Chief Business Officer Sell 42.5 -5,545 -6.94% $73.1K
Mar 11, 2025 Mar 13, 2025 ClearPoint Neuro, Inc. Chief Business Officer Sell 46.3 -2,967 -4.41% $37.7K
Mar 6, 2025 Mar 10, 2025 ClearPoint Neuro, Inc. Chief Business Officer Sell 42.5 -6,361 -9.73% $83.9K
Feb 22, 2025 Feb 25, 2025 ClearPoint Neuro, Inc. Chief Business Officer Sell 46.3 -908 -1.87% $15.2K
Aug 20, 2024 Aug 21, 2024 ClearPoint Neuro, Inc. Chief Business Officer Sell 50.0 -420 -0.86% $4.7K
Jun 10, 2024 Jun 11, 2024 ClearPoint Neuro, Inc. Chief Business Officer Sell 46.3 -2,502 -5.25% $14.4K
Mar 6, 2024 Mar 8, 2024 ClearPoint Neuro, Inc. Chief Business Officer Sell 46.3 -3,180 -6.25% $19.8K
Feb 22, 2024 Feb 23, 2024 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Sell 47.5 -1,039 -2.41% $7.8K
Jul 6, 2023 Jul 7, 2023 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Sell 46.3 -1,730 -3.90% $11.3K
Jun 10, 2023 Jun 13, 2023 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Sell 47.5 -1,212 -2.82% $8.4K
Feb 22, 2023 Feb 23, 2023 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Sell 47.5 -514 -1.18% $4.4K
Dec 30, 2022 Jan 30, 2023 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Buy 77.5 +728 1.71% $5.2K
Aug 20, 2022 Aug 23, 2022 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Sell 52.5 -203 -0.47% $2.7K
Jul 6, 2022 Jul 8, 2022 ClearPoint Neuro, Inc. GM, Biologics & Drug Delivery Sell 46.3 -1,685 -3.90% $23.4K